BEAT

BEAT

USD

Heartbeam Inc. Common Stock

$1.300+0.050 (4.000%)

即時價格

Healthcare
Health Information Services
美國

價格圖表

Loading Chart...

關鍵指標

市場指標
公司基本面
交易統計

市場指標

開盤

$1.250

最高

$1.250

最低

$1.250

交易量

0.02M

公司基本面

市值

44.0M

行業

Health Information Services

國家

United States

交易統計

平均交易量

0.10M

交易所

NCM

貨幣

USD

52週範圍

最低 $1.17當前 $1.300最高 $3.48

相關新聞

BusinessWire

HeartBeam Announces Two New U.S. Patents, Powering Forward Its Robust Patent Portfolio

First patent significantly advances intellectual property for HeartBeam's credit card-sized ECG device, bolstering both the defensive and offensive moat around the company's core technology Second patent expands the

查看更多
HeartBeam Announces Two New U.S. Patents, Powering Forward Its Robust Patent Portfolio
BusinessWire

HeartBeam Appoints CEO Robert Eno to Board of Directors to Support U.S. Commercialization and Growth

Board expansion reflects Company's commitment to leadership and innovation in remote cardiac monitoring HeartBeam, Inc., (NASDAQ:BEAT), a medical technology company focused on transforming cardiac care by providing

查看更多
HeartBeam Appoints CEO Robert Eno to Board of Directors to Support U.S. Commercialization and Growth
BusinessWire

HeartBeam to Host First Quarter 2025 Results Conference Call on Tuesday, May 13, 2025 at 4:30 p.m. Eastern Time

HeartBeam, Inc. (NASDAQ:BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, will hold a conference call on Tuesday, May 13, 2025 at 4:30 p.m. Eastern

查看更多
HeartBeam to Host First Quarter 2025 Results Conference Call on Tuesday, May 13, 2025 at 4:30 p.m. Eastern Time
BusinessWire

HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology

Milestone results formed the basis of HeartBeam's 12-lead ECG synthesis software application submitted to FDA in January 2025 HeartBeam, Inc., (NASDAQ:BEAT), a medical technology company focused on transforming

查看更多
HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology
BusinessWire

HeartBeam and AccurKardia Announce Strategic Collaboration to Advance Cardiac Monitoring Innovation

Collaboration brings together two leaders in ambulatory ECG recording and analysis HeartBeam, Inc. (NASDAQ:BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized

查看更多
HeartBeam and AccurKardia Announce Strategic Collaboration to Advance Cardiac Monitoring Innovation